Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae
Miranda E Pitt, Alysha G Elliott, Duc Cao Minh, Devika Ganesamoorthy, Ilias Karaiskos, Helen Giamarellou, Cely S Abboud, Mark AT Blaskovich, Matthew A Cooper, Lachlan JM Coin
Microbial Genomics | MICROBIOLOGY SOC | Published : 2018
Awarded by Wellcome Trust
Awarded by NHMRC
Awarded by NIH
Awarded by Institute for Molecular Bioscience Centre for Superbug Solutions
LC is an ARC Future Fellow (FT110100972). MAC is an NHMRC Principal Research Fellow (APP1059354) and currently holds a fractional Professorial Research Fellow appointment at the University of Queensland with his remaining time as CEO of Inflazome Ltd, a company headquartered in Dublin, Ireland, that is developing drugs to address clinical unmet needs in inflammatory disease by targeting the inflammasome. MEP is an Australian Postgraduate Award scholar. AGE and MATB are supported in part by a Wellcome Trust Strategic Award 104797/Z/14/Z. Research was supported by NHMRC grants (APP1005350, APP 1045326), an NIH grant (R21AI098731/R33AI098731) and an AID sequencing Grant (2013) as well as funding from the Institute for Molecular Bioscience Centre for Superbug Solutions (610246).